Home » Science and Research Articles » Nextrials Named to the Lead411 Technology 500 List
Nextrials Named to the Lead411 Technology 500 List
Nextrials selected as one of the to 500 technology companies based on percentage of revenue growth
SAN RAMON, CA December 10, 2010 /Science and Research PR News/ -- Nextrials, Inc. (www.nextrials.com), a leader in clinical research software and services, today announced that the company has been selected as one of the top 500 technology companies in the U.S. by Lead411. This is the first time Nextrials has appeared on the annual list of privately held technology companies with over $1M in revenue. Based on its percentage of revenue growth from 2007-2009, Nextrials achieved the ranking of No. 491.
"Despite the national economic slowdown, Nextrials continues to be at the forefront of the clinical research industry, and this leadership is reflected in our revenue growth," noted James Rogers, co-founder and CEO of Nextrials. "Recent milestones include our groundbreaking efforts to integrate electronic data capture (EDC) and electronic health records (EHR) platforms, the significant upgrade of our flagship clinical trial management platform, Prism and our certification for compliance with the federally recognized Healthcare Information Technology Standards Panel's (HITSP) interoperability specifications."
California-based Lead411 was founded in 2001 to provide sales leads and intelligence, business email lists, company and people data. Since its inception, it has grown 40 percent without venture capital financing. The Technology 500 list identifies the fastest growing tech companies in the U.S., and was created to help the company stay on top of trends within the industry.
About Nextrials
Founded by pharmaceutical researchers in 1999, Nextrials offers today's most novel products and services for speeding the delivery of life-saving drugs and medical devices to market. Prism , its award-winning Electronic Data Capture (EDC) solution, has been used at over 1,500 research sites to streamline the initiation and management of clinical trials. The company is headquartered in the San Francisco Bay area. For more information, visit www.nextrials.com or call 925-355-3000.
Contact:
Rachel V. Berry
VOXUS, Inc.
253-444-5441
rberry@voxuspr.com
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com |
|
|
Press Release Contact Information:
Rachel Berry
VOXUS, Inc.
Program Director
117 South 8th
Tacoma, WA
USA 98402
Voice: 253-853-5151
Fax: 253-853-5110
Website: Visit Our Website |
|
|
|
|
| SCIENCE AND RESEARCH ARCHIVE SEARCH |
|
|
| |
| SUBMIT SCIENCE AND RESEARCH NEWS |
|
|
| |
|
|
Advertise With Us |
About Us |
Contact Us